83 related articles for article (PubMed ID: 9889031)
21. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
22. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC).
Alici S; Saip P; Eralp Y; Aydiner A; Topuz E
Am J Clin Oncol; 2003 Aug; 26(4):358-62. PubMed ID: 12902885
[TBL] [Abstract][Full Text] [Related]
23. Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot study.
Kurtz JE; Deplanque G; Duclos B; Eichler F; Giron C; Limacher JM; Herbrecht R; Maloisel F; Oberling F; Bergerat JP; Dufour P
Gynecol Oncol; 1998 Sep; 70(3):414-7. PubMed ID: 9790797
[TBL] [Abstract][Full Text] [Related]
24. Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.
Markman M; Kennedy A; Sutton G; Hurteau J; Webster K; Peterson G; Kulp B; Belinson J
Gynecol Oncol; 1998 Aug; 70(2):272-4. PubMed ID: 9740704
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel in patients with platinum-resistant ovarian cancer: a selected review of literature and clinical experience.
Kudelka AP; Tresukosol D; Gonzalez de Leon C; Termrungruanglert W; Edwards CL; Freedman RS; Tornos C; Kavanagh JJ
J Med Assoc Thai; 1996 Apr; 79(4):240-5. PubMed ID: 8708510
[TBL] [Abstract][Full Text] [Related]
26. Phase 2 trial of moderately high dose single agent mitoxantrone in platinum and paclitaxel-refractory ovarian cancer.
Markman M; Lichtman SM; Homesley H; Kennedy A; Webster K; Ernst S; Omura G; Belinson J
Gynecol Oncol; 1998 Jul; 70(1):123-6. PubMed ID: 9698488
[TBL] [Abstract][Full Text] [Related]
27. Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the Mario Negri Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group.
Buda A; Floriani I; Rossi R; Colombo N; Torri V; Conte PF; Fossati R; Ravaioli A; Mangioni C
Br J Cancer; 2004 Jun; 90(11):2112-7. PubMed ID: 15150623
[TBL] [Abstract][Full Text] [Related]
28. Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study.
Miglietta L; Amoroso D; Bruzzone M; Granetto C; Catsafados E; Mammoliti S; Guarneri D; Pedulla F; Foglia G; Ragni N; Martini MC; Brema F; Addamo G; Moraglio L; Pastorino G; Boccardo F
Oncology; 1997; 54(2):102-7. PubMed ID: 9075779
[TBL] [Abstract][Full Text] [Related]
29. Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial.
Carlson JW; Fowler JM; Mitchell SK; Carson LF; Mayer AR; Copeland LJ
Gynecol Oncol; 1997 May; 65(2):325-9. PubMed ID: 9159346
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.
Parmar MK; Ledermann JA; Colombo N; du Bois A; Delaloye JF; Kristensen GB; Wheeler S; Swart AM; Qian W; Torri V; Floriani I; Jayson G; Lamont A; Tropé C;
Lancet; 2003 Jun; 361(9375):2099-106. PubMed ID: 12826431
[TBL] [Abstract][Full Text] [Related]
31. Epidoxorubicin versus no treatment as consolidation therapy in advanced ovarian cancer: results from a phase II study.
Bolis G; Danese S; Tateo S; Rabaiotti E; D'Agostino G; Merisio C; Scarfone G; Polverino G; Parazzini F
Int J Gynecol Cancer; 2006; 16 Suppl 1():74-8. PubMed ID: 16515571
[TBL] [Abstract][Full Text] [Related]
32. Taxol administration.
Rutherford C
J Intraven Nurs; 1994; 17(3):139-43. PubMed ID: 7914922
[TBL] [Abstract][Full Text] [Related]
33. Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistant paclitaxel-pretreated ovarian cancer.
Aravantinos G; Dimopoulos MA; Kosmidis P; Bafaloukos D; Papadimitriou C; Kiamouris C; Pavlidis N; Sikiotis K; Papakostas P; Skarlos DV
Ann Oncol; 2000 May; 11(5):607-12. PubMed ID: 10907957
[TBL] [Abstract][Full Text] [Related]
34. A retrospective review of paclitaxel-associated gastrointestinal necrosis in patients with epithelial ovarian cancer.
Seewaldt VL; Cain JM; Goff BA; Tamimi H; Greer B; Figge D
Gynecol Oncol; 1997 Nov; 67(2):137-40. PubMed ID: 9367696
[TBL] [Abstract][Full Text] [Related]
35. [Anthracyclines in therapy of ovarian carcinoma: a systematic review of primary and 2nd-line therapy after platinum].
du Bois A; Lück HJ; Pfisterer J; Meier W; Bauknecht T
Zentralbl Gynakol; 2000; 122(5):255-67. PubMed ID: 10857212
[TBL] [Abstract][Full Text] [Related]
36. Prolonged stabilization of progressive platinum-refractory ovarian cancer with paclitaxel: brief report.
Balat O; Kudelka AP; Tunca JC; Edwards CL; Verschraegen C; Kavanagh JJ
Eur J Gynaecol Oncol; 1996; 17(4):264-6. PubMed ID: 8856300
[TBL] [Abstract][Full Text] [Related]
37. Pharmacologic study of 3-hour 135 mg M-2 paclitaxel in platinum pretreated patients with advanced ovarian cancer.
Panday VR; Huizing MT; van Warmerdam LJ; Dubbelman RC; Mandjes I; Schellens JH; Huinink WW; Beijnen JH
Pharmacol Res; 1998 Sep; 38(3):231-6. PubMed ID: 9782075
[TBL] [Abstract][Full Text] [Related]
38. Epidoxorubicin and lonidamine in refractory or recurrent epithelial ovarian cancer.
Gadducci A; Brunetti I; Muttini MP; Fanucchi A; Dargenio F; Giannessi PG; Conte PF
Eur J Cancer; 1994; 30A(10):1432-5. PubMed ID: 7833097
[TBL] [Abstract][Full Text] [Related]
39. Treatment of refractory ovarian carcinoma with paclitaxel and cisplatin after treatment failure with single-agent paclitaxel.
Johnston CM; Pearl ML; Reynolds RK; Roberts JA; Morley GW
Eur J Gynaecol Oncol; 1995; 16(6):439-47. PubMed ID: 8536758
[TBL] [Abstract][Full Text] [Related]
40. USA update on paclitaxel in ovarian cancer.
Ozols RF
Ann Med; 1995 Feb; 27(1):127-30. PubMed ID: 7741991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
